Intramuscular botulinum toxin prior to comprehensive rehabilitation has no added value for improving motor impairments, gait kinematics and goal attainment in walking children with spastic cerebral palsy

Objective: Botulinum toxin (BoNT-A) is widely used in combined treatment for spastic cerebral palsy, but its added value preceding comprehensive rehabilitation for motor impairments, gait, and goal attainment has not been studied. Design: A comparative multi-centre trial, i...

Full description

Bibliographic Details
Main Authors: Fabienne Schasfoort, Robert Pangalila, Emiel M. Sneekes, Coriene Catsman, Jules Becher, Herwin Horemans, Henk J. Stam, Annet J. Dallmeijer, Johannes B.J Bussmann
Format: Article
Language:English
Published: Foundation for Rehabilitation Information 2018-07-01
Series:Journal of Rehabilitation Medicine
Subjects:
Online Access: https://www.medicaljournals.se/jrm/content/html/10.2340/16501977-2369